Naftidrofuryl exerts antiserotonergic but no endothelin-receptor blocking effects in AS4.1 cells, juxtaglomerular cells and isolated perfused rat kidneys.
Journal of cardiovascular pharmacology • Vol. 39, Issue 1 • 2002
Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program.
International angiology : a journal of the International Union of Angiology • Vol. 21, Issue 1 • 2002
A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
International angiology : a journal of the International Union of Angiology • Vol. 20, Issue 1 • 2001
New treatment options in intermittent claudication: the US experience.
International journal of clinical practice. Supplement, Issue 119 • 2001